v3.26.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating expenses:    
Research and development [1] $ 29,145 $ 19,925
General and administrative [2] 7,289 5,161
Total operating expenses 36,434 25,086
Loss from operations (36,434) (25,086)
Other income (expense):    
Interest income 4,606 4,092
Other income (expense), net 8 (5)
Total other income, net 4,614 4,087
Net loss $ (31,820) $ (20,999)
Common Stockholders    
Other income (expense):    
Net loss per share attributable to stockholders, basic (in Dollars per share) $ (0.48) $ (0.4)
Net loss per share attributable to stockholders, Diluted (in Dollars per share) $ (0.48) $ (0.4)
Weighted-average shares used in computing net loss per share attributable to stockholders, basic (in Shares) 55,172,410 41,679,560
Weighted-average shares used in computing Net loss per share attributable to stockholders, diluted (in Shares) 55,172,410 41,679,560
Series B Non-Voting Convertible Preferred Stockholders    
Other income (expense):    
Net loss per share attributable to stockholders, basic (in Dollars per share) $ (39.81) $ (32.95)
Net loss per share attributable to stockholders, Diluted (in Dollars per share) $ (39.81) $ (32.95)
Weighted-average shares used in computing net loss per share attributable to stockholders, basic (in Shares) 137,138 137,138
Weighted-average shares used in computing Net loss per share attributable to stockholders, diluted (in Shares) 137,138 137,138
[1] Includes related party amounts of $3,000 and $2,122 for the three months ended March 31, 2026 and 2025, respectively
[2] Includes related party amounts of $4 and $110 for the three months ended March 31, 2026 and 2025, respectively